Clinical trials in locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Crane, Christopher H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.PANCA2014-IA27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA27
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CA 19-9 as a Predictor of CT Response for Patients With Locally Advanced Pancreatic Cancer (LAPC)
    Moskovic, D. J.
    Carlson, P.
    Dakik, H.
    Qiao, W.
    Javle, M.
    Fogelman, D. R.
    PANCREAS, 2009, 38 (08) : 1029 - 1029
  • [22] Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC)
    Skinner, Heath Devin
    Javle, Milind M.
    Wolff, Robert A.
    Clemons, Marilyn V.
    Munsell, Mark F.
    Delclos, Marc E.
    Fleming, Jason B.
    Das, Prajnan
    Crane, Christopher H.
    Krishnan, Sunil
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [23] Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy
    Hartlapp, Ingo
    Mueller, Justus
    Kenn, Werner
    Steger, Ulrich
    Isbert, Christoph
    Scheurlen, Michael
    Germer, Christoph-Thomas
    Einsele, Hermann
    Kunzmann, Volker
    ONKOLOGIE, 2013, 36 (03): : 123 - 125
  • [24] Efficacy and toxicity of limited field concurrent chemoradiotherapy (CRT) with capecitabine for locally advanced pancreatic cancer (LAPC)
    Jain, P.
    Watkins, G.
    Jackson, A.
    Dickinson, C.
    Whitfield, G.
    Rembielak, A.
    Valle, J. W.
    Taylor, M. B.
    Price, P. M.
    Saleem, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Risk Adapted Ablative Radiotherapy (RAdAR) after Intensive Chemotherapy for Locally Advanced Pancreatic Cancer (LAPC)
    Rossi, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E72 - E72
  • [26] A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer
    Ambe C.
    Fulp W.
    Springett G.
    Hoffe S.
    Mahipal A.
    Journal of Gastrointestinal Cancer, 2015, 46 (3) : 284 - 290
  • [27] Clinical impact of radiotherapy for locally advanced pancreatic cancer
    Sawaki, Akira
    Hoki, Noriyuki
    Ito, Satoko
    Matsumoto, Kazuya
    Mizuno, Nobumasa
    Hara, Kazuo
    Takagi, Tadayuki
    Kobayashi, Yuji
    Sawai, Yugo
    Kawai, Hiroki
    Tajika, Masahiro
    Nakamura, Tsuneya
    Yamao, Kenji
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (12) : 1209 - 1214
  • [28] Clinical impact of radiotherapy for locally advanced pancreatic cancer
    Akira Sawaki
    Noriyuki Hoki
    Satoko Ito
    Kazuya Matsumoto
    Nobumasa Mizuno
    Kazuo Hara
    Tadayuki Takagi
    Yuji Kobayashi
    Yugo Sawai
    Hiroki Kawai
    Masahiro Tajika
    Tsuneya Nakamura
    Kenji Yamao
    Journal of Gastroenterology, 2009, 44 : 1209 - 1214
  • [29] X-ray volumetric imaging (XVI) to redefine radiotherapy margins for locally advanced pancreatic cancer (LAPC)
    Jain, P.
    Amer, A.
    Stratford, J.
    Saleem, A.
    Moore, C.
    Price, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S33 - S33
  • [30] Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC)
    Field, Wesley
    Rostas, Jack W.
    Martin, Robert C. G.
    AMERICAN JOURNAL OF SURGERY, 2019, 218 (03): : 571 - 578
12345